| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/20/2001 | US20010023242 Polypeptide from snake venom |
| 09/20/2001 | US20010022977 Administering apoptosis agent |
| 09/20/2001 | US20010022976 Controlling lymphocyte activation, tumor necrosis factor |
| 09/20/2001 | DE10012732A1 Thrombin composition, for use as hemostatic or as a component of fibrin glues, comprises non-covalently bonded inhibitor for stabilization |
| 09/20/2001 | DE10005329A1 Stimulating growth of hair, e.g. on the head, eyebrows or eyelashes, by subcutaneous application of a preparation containing stem cells and/or preformed hair cells |
| 09/20/2001 | CA2674427A1 A method of sorting cells |
| 09/20/2001 | CA2403205A1 Compositions and methods of regulated protein expression in gut endocrine k cells |
| 09/20/2001 | CA2403120A1 Method for in vitro production of three-dimensional vital cartilage or bone tissue and use thereof as transplant material |
| 09/20/2001 | CA2403084A1 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 09/20/2001 | CA2403000A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 09/20/2001 | CA2402721A1 Derivatives of breast cancer antigen her-2 for therapeutical use |
| 09/20/2001 | CA2402639A1 L-leucyl-l-leucine methyl ester treatment of donor lypmhocyte infusions in hematopoietic stem cell transplant patients |
| 09/20/2001 | CA2402413A1 Compositions and methods for affecting osteogenesis |
| 09/20/2001 | CA2402265A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 09/20/2001 | CA2402245A1 Multipotent cell and cardiomyocyte cell populations, and routes to and uses of same |
| 09/20/2001 | CA2402041A1 Antisense oligonucleotides of the human chk1 gene and uses thereof |
| 09/20/2001 | CA2373110A1 Production of chimeric capsid vectors |
| 09/19/2001 | EP1133994A1 A method for reversing the immunosuppressive effects of the Melanoma Inhibitory Activity "MIA" |
| 09/19/2001 | EP1133991A1 Bacteriostatic compositions for salmonellae |
| 09/19/2001 | EP1133990A1 Anti-tumor composition consisting of a fraction of gravid uterus or mammalian placenta |
| 09/19/2001 | EP1133555A2 Pharmaceutical factor vii preparation |
| 09/19/2001 | EP1133552A2 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
| 09/19/2001 | EP1133316A1 Formulation of adenovirus for gene therapy |
| 09/19/2001 | EP1133313A2 Calcitonin for the modulation of sperm function |
| 09/19/2001 | EP1133310A2 Artery- and vein-specific proteins and uses therefor |
| 09/19/2001 | EP1133308A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases |
| 09/19/2001 | EP0862634B1 Pharmaceutical composition for treating papillomavirus tumours and infection |
| 09/19/2001 | EP0831901B1 Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein |
| 09/19/2001 | EP0700300B1 Purification of plasma proteins |
| 09/19/2001 | EP0593755B1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment |
| 09/19/2001 | CN1313727A Method and device for rearing insects, especially for obtaining a secretion from fly larvae for therapeutic application |
| 09/19/2001 | CN1313124A Ointment for treating burn and its preparing process |
| 09/19/2001 | CN1313121A Medicine for treating sciatic nerve diseases |
| 09/19/2001 | CN1313115A Medicinal pill for taking care of heart health |
| 09/19/2001 | CN1313114A Medicine for treating female dimacteric syndrome and its preparing process |
| 09/19/2001 | CN1313113A Medicine for treating mental diseases (psychosis) |
| 09/19/2001 | CN1313111A Health-care medical wine for invigorating function of kidney and strengthening bone |
| 09/19/2001 | CN1313108A Composite non-opium medicine for dropping drugs |
| 09/19/2001 | CN1313107A Chinese medicine for prepventing and treating iatrogenic hypercortisonism |
| 09/19/2001 | CN1313106A Broad-spectrum antibacterial Huangru Ointment for treating deep burn |
| 09/19/2001 | CN1313101A Capsules of Biyang Yak penis |
| 09/19/2001 | CN1313095A Process for preparing plaster to promote circulation of blood and vital energy |
| 09/19/2001 | CN1313094A Tonic oral liquid for building up body |
| 09/19/2001 | CN1313093A Detoxicating pill 'Niuhuang Yincui' |
| 09/19/2001 | CN1313092A Improved process for preparing medicinal assistant |
| 09/19/2001 | CN1313091A Bone strengthening capsules of Biyang yak bone marrow |
| 09/19/2001 | CN1313090A Quick-acting berberi powder |
| 09/19/2001 | CN1071130C Preparation used for orthopedics and its preparing process |
| 09/19/2001 | CN1071129C Pill for relief of choke |
| 09/19/2001 | CN1071126C Chinese medicine preparation for curing hyperplasia of prostate and preparing process thereof |
| 09/19/2001 | CN1071125C Bathing medicine for preventing and curing valva disease |
| 09/19/2001 | CN1071122C Chinese medicine preparation for treating prospermia and preventing improtence |
| 09/19/2001 | CN1071119C Enzymolytic pearl liquor |
| 09/18/2001 | US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject. |
| 09/18/2001 | US6291430 Mage-3 peptides presented by HLA class II molecules |
| 09/18/2001 | US6291240 Cells or tissues with increased protein factors and methods of making and using same |
| 09/18/2001 | US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors |
| 09/18/2001 | US6291236 Human cytomegalovirus DNA sequences |
| 09/18/2001 | US6291211 Expressing heterologous polypeptides in cells; incubate cells with expression vectors, transform cells, express heterologous polypeptide |
| 09/18/2001 | US6290964 Isolated from the clear gel isolated from the whole leaf of the aloe vera plant. |
| 09/18/2001 | US6290712 Laser/sensitizer assisted immunotherapy |
| 09/18/2001 | CA2735316A1 Thrombin preparations and process for their production |
| 09/18/2001 | CA2194485C Endothelial lining effects and treatment of vasospastic disorders |
| 09/13/2001 | WO2001066699A2 P27 and p21 in gene therapies |
| 09/13/2001 | WO2001066698A1 Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| 09/13/2001 | WO2001066572A2 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 09/13/2001 | WO2001066559A1 INHIBITION OF Tp12 TO TREAT INFLAMMATORY DISEASES |
| 09/13/2001 | WO2001066150A2 Highly efficient gene transfer into human repopulating stem cel ls by rd114 pseudotyped retroviral vector particles |
| 09/13/2001 | WO2001066148A1 A method of sensitising endothelial cells to prodrugs |
| 09/13/2001 | WO2001066137A1 Adenovirus formulations |
| 09/13/2001 | WO2001066120A1 Nerve growth assistance improvement |
| 09/13/2001 | WO2001065934A2 Applications of immune system tolerance to treatment of various diseases |
| 09/13/2001 | WO2001026666A3 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 09/13/2001 | WO2001017536A3 Novel autogenous vaccines used to obtain an immune tolerance |
| 09/13/2001 | WO2001016288A3 Dna encoding the human serine protease c-e |
| 09/13/2001 | WO2001005480A3 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 09/13/2001 | WO2001004282A3 Replication-competent anti-cancer vectors |
| 09/13/2001 | WO2000041731A9 Reverse gene therapy |
| 09/13/2001 | WO2000040701A9 Non-myeloablative tolerogenic treatment |
| 09/13/2001 | WO2000034780A8 METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ¿3? |
| 09/13/2001 | US20010021723 Histochrome and its therapeutic use in ophthalmology |
| 09/13/2001 | US20010021701 Contacting the ductal epithelium of the exocrine gland with epithelium destroying agents such as ethanol and vaccinia virus |
| 09/13/2001 | US20010021697 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 09/13/2001 | US20010021694 Treating bulimia and eating disorders, stimulating cholecystokinin, protein powder with glycomacropeptide or casein, fatty acid, fiber |
| 09/13/2001 | US20010021395 Mixture of nucleic acid and anticancer agent |
| 09/13/2001 | US20010021393 Antibodies from eggs immunized with urease of Helicobacter |
| 09/13/2001 | DE10010113A1 Isolation of collagen by extraction from sponge, giving product having cyclooxygenase inhibiting activity, useful for treating inflammatory diseases such as arthritis or skin inflammation |
| 09/13/2001 | CA2799545A1 Adenovirus formulations |
| 09/13/2001 | CA2402602A1 Polynucleotides which are of nature b2/d+ a- and which are isolated from e. coli, and biological uses of these polynucleotides and of their polypeptides |
| 09/13/2001 | CA2402027A1 A method of sensitising endothelial cells to prodrugs |
| 09/12/2001 | EP1132478A2 Helper virus for the preparation of recombinant viral recombinants |
| 09/12/2001 | EP1132463A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor |
| 09/12/2001 | EP1132091A1 Treatment for diabetes |
| 09/12/2001 | EP1131458A1 Viral vectors with late transgene expression |
| 09/12/2001 | EP1131457A1 Systemic viral/ligand gene delivery system and gene therapy |
| 09/12/2001 | EP1131411A2 Suppression of xenotransplant rejection |
| 09/12/2001 | EP1131410A1 Bioengineered tissue constructs and methods for producing and using them |
| 09/12/2001 | EP1131408A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 09/12/2001 | EP1131407A1 Serum free medium for chondrocyte-like cells |
| 09/12/2001 | EP1131406A2 Low oxygen culturing of central nervous system progenitor cells |